| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 09/08/2004 | CN1527831A Antagonists of MCP-q function and method of use thereof |
| 09/08/2004 | CN1527830A Ether derivatives useful as inhibitors of PDE4 isozymes |
| 09/08/2004 | CN1527828A 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 09/08/2004 | CN1527824A Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
| 09/08/2004 | CN1527814A Nitric oxide synthase inhibitor phosphate salt |
| 09/08/2004 | CN1527813A ANtioxidant nitroxides and nitrones as therapeutic agents |
| 09/08/2004 | CN1527718A Method for short-term and long-term drug dosimetry |
| 09/08/2004 | CN1527705A Pharma ceutical formulation containing and LTB4 antagonist |
| 09/08/2004 | CN1526428A Rhinitis treating medicine and its prepn process |
| 09/08/2004 | CN1526415A Medicine composition for treating cold |
| 09/08/2004 | CN1526386A Houttuynin sodium powder injection and its prepn |
| 09/08/2004 | CN1165533C Spiropiperidine derivatives |
| 09/08/2004 | CN1165522C Bradykinin receptor antagonists |
| 09/08/2004 | CN1165518C Biocyclic amino acids compound compound as pharmaceutical agents |
| 09/08/2004 | CN1165337C Synthetic cryptophycins |
| 09/08/2004 | CN1165327C New prepn process of Saorilao oral liquid as one traditional Mongoliam medicine |
| 09/08/2004 | CN1165325C New prepn process of Manu as one traditional Mongolian medicine |
| 09/08/2004 | CN1165308C Compositions and method for reducing respiratory depression and attendant side effect of mu opioid compounds |
| 09/08/2004 | CN1165302C Medical use of andrographolide and its derivatives |
| 09/07/2004 | US6787672 1-(4-methoxyphenyl)-3-(3,5-dimethoxyphenyl)prop-1-en-3-one derivatives; antiproliferative and antiinflammatory agents |
| 09/07/2004 | US6787652 Lowering lipids and serum cholesterol without generating adverse cardiac effects; 4,5-dihydro-3,5-dioxo-1,2,4-triazine derivatives |
| 09/07/2004 | US6787554 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives |
| 09/07/2004 | US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/07/2004 | US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles |
| 09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
| 09/07/2004 | US6787539 2,4,5,-trisubstituted pyrimidine derivatives |
| 09/07/2004 | US6787536 Hydroxamic acid derivatives |
| 09/07/2004 | US6787532 Formulation containing anti-inflammatory androstane derivatives |
| 09/02/2004 | WO2004074438A2 Ccr8 antagonists |
| 09/02/2004 | WO2004074297A1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators |
| 09/02/2004 | WO2004074277A1 N-aryl- or n-heteroarylpiperazine derivative and medicine containing the same |
| 09/02/2004 | WO2004074240A1 Prostaglandin derivatives |
| 09/02/2004 | WO2004073748A1 Aqueous suspension medicine |
| 09/02/2004 | WO2004073737A1 Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3 |
| 09/02/2004 | WO2004073619A2 Ccr8 antagonists |
| 09/02/2004 | WO2004073586A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor tg1019 (tg1019) |
| 09/02/2004 | WO2004062551A3 RECOMBINANT VHH SINGLE DOMAIN ANTIBODY FROM CAMELIDAE AGAINST VON WILLEBRAND FACTOR (vWF) OR AGAINST COLLAGEN |
| 09/02/2004 | WO2004037187A3 Metal-containing materials, compositions and methods |
| 09/02/2004 | WO2003101375A3 Immunostimulatory oligonucleotides and uses thereof |
| 09/02/2004 | WO2003084539A3 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 09/02/2004 | US20040171839 Serine protease inhibitor; therapy for thrombosis , cardiovascular disorders |
| 09/02/2004 | US20040171830 Carboline derivatives as pdev inhibitors |
| 09/02/2004 | US20040171828 Respiratory system disorders; asthma; antihistamines |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171802 Haemophilus influenzae antigens and corresponding dna fragments |
| 09/02/2004 | US20040171679 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 09/02/2004 | US20040171676 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
| 09/02/2004 | US20040171639 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 09/02/2004 | US20040171623 thieno[2,3-d]pyrimidinediones; modulation of autoimmune disease |
| 09/02/2004 | US20040171618 Compounds as PDE IV and TNF-inhibitors |
| 09/02/2004 | US20040171616 preventing and treating thrombotic conditions, such as coronary artery disease, cerebrovascular disease, and other coagulation related disorders |
| 09/02/2004 | US20040171607 Chemical compounds |
| 09/02/2004 | US20040171597 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| 09/02/2004 | US20040171581 Polysaccharidic esters of retinoic acid |
| 09/02/2004 | US20040171576 with the proviso that the anticholinergic agent is not a tiotropium salt; asthma, chronic obstructive pulmonary disease |
| 09/02/2004 | US20040171546 Regulation of lung tissue by hedgehog-like polypeptides and formulations and uses related thereto |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171012 Nucleic acid-associated proteins |
| 09/02/2004 | US20040170999 Nuclear hormone receptor ligand binding domain |
| 09/02/2004 | US20040170997 used in drug screening for preventing or treating diseases associated with abnormalities in intracellular signal transduction; genetic engineering |
| 09/02/2004 | US20040170995 for drug screening in vitro for mitogen-activated protein kinase-activated protein kinase-2 modulators using expression libraries; genetic engineering; kits |
| 09/02/2004 | US20040170750 Edible composition and dosage form comprising an edible shell |
| 09/02/2004 | US20040170690 Tablet comprising cetirizine and pseudoephedrine |
| 09/02/2004 | US20040170623 having a concentration of at least 50 mg/ml of the antibody and containing an acidic component; nasal sprays and slow release formulations drying or freeze-drying |
| 09/02/2004 | US20040170618 antagonists bind to a recognized target (e.g., a receptor); the enzyme component of the chimera then degrades the target resulting in a reduction of activity of the target and release of the chimeric molecule, which is then free to attack and degrade another target molecule. |
| 09/02/2004 | US20040170568 Stabilized preparations for use in metered dose inhalers |
| 09/02/2004 | CA2515978A1 Vaccination or immunization using a prime-boost regimen against bhv-1 |
| 09/01/2004 | EP1452542A2 Reshaped human monoclonal antibodies specific for IgE |
| 09/01/2004 | EP1452524A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
| 09/01/2004 | EP1452522A2 Novel compounds and compositions as protease inhibitors |
| 09/01/2004 | EP1452179A1 Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid |
| 09/01/2004 | EP1451192A1 Novel crystalline compound |
| 09/01/2004 | EP1451191A1 Thioether substituted imidazoquinolines |
| 09/01/2004 | EP1451190A1 Triazolo(4,3-a)pyrido(2,3-d)pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof |
| 09/01/2004 | EP1451187A1 Amide substituted imidazopyridines |
| 09/01/2004 | EP1451186A2 Urea substituted imidazopyridines |
| 09/01/2004 | EP1451184A1 Dimeric compounds and their use as anti-viral agents |
| 09/01/2004 | EP1451181A1 Dimeric compounds and their use as anti-viral agents |
| 09/01/2004 | EP1451174A2 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
| 09/01/2004 | EP1451167A1 Phenylalkynes |
| 09/01/2004 | EP1451165A1 Substituted benzoxazoles and analogues as estrogenic agents |
| 09/01/2004 | EP1451154A2 Inhibitors of cytosolic phospholipase a2 |
| 09/01/2004 | EP1451153A1 Nk1 antagonists |
| 09/01/2004 | EP1450859A2 Methods and compositions for the diagnosis of asthma |
| 09/01/2004 | EP1450837A2 Interleukin-1 receptors in the treatment of diseases |
| 09/01/2004 | EP1450836A2 Method for short-term and long-term drug dosimetry |
| 09/01/2004 | EP1450831A2 Methods of treatment in situ in the lungs of mammals |
| 09/01/2004 | EP1450820A2 Method for treating or preventing inflammatory diseases |
| 09/01/2004 | EP1450819A1 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection |
| 09/01/2004 | EP1450811A2 2-aryl pyrrolopyrimidines for a1 and a3 receptors |
| 09/01/2004 | EP1450803A1 New uses for anti-malarial therapeutic agents |
| 09/01/2004 | EP1450797A1 Benzothiazole derivatives |
| 09/01/2004 | EP1450796A1 Benzothiazole derivatives |
| 09/01/2004 | EP1450792A1 Benzazole derivatives for the treatment of scleroderma |
| 09/01/2004 | EP1450791A1 Hydrazonopyrazole derivatives and their use as therapeutics |
| 09/01/2004 | EP1450783A1 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma |
| 09/01/2004 | EP1450780A1 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 09/01/2004 | EP1450777A1 Pharmaceutical composition containing chalcone or its derivatives for matrix metalloproteinase inhibitory activity |
| 09/01/2004 | EP1450775A2 Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections |
| 09/01/2004 | EP1450772A1 Micronized film-forming powder comprising an active substance |